XERIS BIOPHARMA HOLDINGS, INC. (XERS) Free cash flow 2020–2021
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$96.6MFY2021 · since FY2020: -$80.9M → -$96.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -$96.6M | -19.4% |
| FY2020 | -$80.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice